First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Shares Down 0% – Should You Sell?

by · The Cerbat Gem

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report) shares were down 0% on Wednesday . The company traded as low as $207.86 and last traded at $208.73. Approximately 22,305 shares traded hands during mid-day trading, a decline of 88% from the average daily volume of 182,409 shares. The stock had previously closed at $208.77.

First Trust NYSE Arca Biotechnology Index Fund Trading Down 0.0%

The business’s 50 day moving average price is $202.47 and its two-hundred day moving average price is $203.21. The company has a market capitalization of $2.36 billion, a price-to-earnings ratio of 21.72 and a beta of 0.70.

Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund

Several hedge funds have recently added to or reduced their stakes in FBT. First Trust Advisors LP boosted its position in First Trust NYSE Arca Biotechnology Index Fund by 0.8% during the 2nd quarter. First Trust Advisors LP now owns 8,393 shares of the company’s stock worth $1,355,000 after buying an additional 66 shares during the period. Baird Financial Group Inc. boosted its position in First Trust NYSE Arca Biotechnology Index Fund by 12.9% during the 2nd quarter. Baird Financial Group Inc. now owns 8,039 shares of the company’s stock worth $1,297,000 after buying an additional 916 shares during the period. Benjamin Edwards Inc. boosted its position in First Trust NYSE Arca Biotechnology Index Fund by 40.5% during the 2nd quarter. Benjamin Edwards Inc. now owns 28,808 shares of the company’s stock worth $4,648,000 after buying an additional 8,304 shares during the period. Two Sigma Securities LLC boosted its position in First Trust NYSE Arca Biotechnology Index Fund by 56.5% during the 2nd quarter. Two Sigma Securities LLC now owns 2,001 shares of the company’s stock worth $323,000 after buying an additional 722 shares during the period. Finally, Corient Private Wealth LLC acquired a new stake in First Trust NYSE Arca Biotechnology Index Fund during the 2nd quarter worth approximately $692,000.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

(Get Free Report)

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.

See Also